Why is fast biomarker testing important in LUNG CANCER? 🤔 🧬BIOMARKER TESTING? By analyzing tumor tissue or blood samples, doctors can learn the details of a patient’s specific tumor. If certain biomarkers are identified, cancer therapy can be personalized for each patient which often means more effective therapies. 🏎️ FAST? Patients often receive sub-optimal treatment, rapidly deteriorate or even die while waiting for their biomarker test results(1-3). Patients should be given the most effective treatment first time around, since this not only alleviates patient anxiety(4-5), but also impacts their overall rate of survival(6). 👉 Biomarker results in only 3 hours for fast treatment decisions! THINK IDYLLA™ https://lnkd.in/gh9nKbMA #Biocartis #Idylla #BiomarkerTesting #PersonalizedMedicine #PrecisionMedicine #LungCancer #NSCLC Sources: https://lnkd.in/eXpHiNkQ
Biocartis
Medical Equipment Manufacturing
High precision diagnostics for personalized medicine
About us
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Our proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs with a focus in oncology, and expanding its test menu in infectious diseases with partners. These areas represent respectively the fastest and largest growing segments of the US$6.5 billion molecular diagnostics market. Biocartis’ vision is to enable personalized medicine for patients around the world through universal access to molecular testing. Our mission is to make molecular testing actionable, convenient, fast and suitable for any lab. Biocartis employs over 500 people and is headquartered in Mechelen, Belgium. Further information? Visit www.biocartis.com
- Website
-
http://www.biocartis.com
External link for Biocartis
- Industry
- Medical Equipment Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Mechelen
- Type
- Privately Held
- Founded
- 2007
- Specialties
- Molecular Diagnostics Solutions, Oncology, and Infectious Diseases
Locations
-
Primary
Get directions
Generaal de Wittelaan
11B
Mechelen, 2800, BE
-
Get directions
2 Pierce Palace
Suite 1510
Itasca, Itasca 60143, US
-
Get directions
Guangzhou, CN
Employees at Biocartis
-
Gina Wallar
-
Karl vom Berge
Currently taking a sabbatical to explore new opportunities and grow personally. Excited to return with fresh perspectives. Open to discuss…
-
Geert Verhoeven
Head of ICT at Biocartis
-
Christine Kuslich, PhD
Corporate Board Director |Advisor| CSO | C-Suite Executive | Chief Scientific Officer at Hologic & GE
Updates
-
HepatoPredict, a prognostic tool supporting the decision of liver transplantation in hepatocellular carcinoma ♥️. 👉 https://kntn.ly/204e16d5 Developed by Ophiomics, distributed by Biocartis. #LiverTransplantation #Biocartis #Ophiomics #HepatoCellularCarcinoma #HCC #LT #LiverCancer #HepatoPredict
-
-
Enjoy your summer vacation☀️ while your fully automated #Idylla™ keeps running #molecular #biomarker tests! 🌴🍹 Get your molecular biomarker results in only 3 hours 🔬 💡THINK IDYLLA™ #ThinkIdylla #Biocartis #Oncology #Pathology #BiomarkerResults #PrecisionMedicine
-
-
Get your molecular biomarker results in only 3 hours 🔬 💡 THINK IDYLLA™ Today, Biocartis offers tests supporting melanoma, colorectal, lung, breast, thyroid, brain, blood and liver cancer. More information 👉 https://lnkd.in/gh9nKbMA #Biocartis #Idylla #ThinkIdylla #EGFR #KRAS #BRAF #MSI #ALK #ROS1 #RET #MET #NTRK #NRAS #PIK3CA #AKT1 #IDH #POLE #Oncology #Pathology #melanoma #colorectalcancer #CRC #lungcancer #breastcancer #thyroidcancer #braincancer #bloodcancer #livercancer
-
Last weekend, we had the pleasure of attending the 2024 Stars in the Mountains (19-21 July) in Vail, CO, USA! ⛰ Next stop, the American Association of Pathologists' Assistants (AAPA) 2024 Summer Meeting (22-24 July) in San Diego, CA! See you there? 👋 Molecular biomarker results in only 3 hours! 💡THINK IDYLLA™ #Biocartis #Idylla #ThinkIdylla #EGFR #KRAS #BRAF #MSI #ALK #ROS1 #RET #MET #NTRK #NRAS #PIK3CA #AKT1 #IDH #POLE #Oncology #Pathology #AAPA2024 #AAPAsummer2024 Cedric Hahn, PhD
-
-
Do you know the difference between NSCLC and SCLC? 🤔 👉 NSCLC = non-small cell lung cancer - Cells are large 🔬 - Common - Often develops slowly - Typically identified at a later stage 👉 SCLC = small cell lung cancer - Cells are small and round 🔬 - Less common - More aggressive - Spreads quickly and to other parts of your body 👀 Discover the Biocartis NSCLC Portfolio: https://lnkd.in/eqtSyBx2 #Biocartis #Idylla #NSCLC #SCLC #LungCancer #EGFR #GeneFusion
-
We're #hiring a new Quality Systems Manager in Mechelen, Flemish Region. Apply today or share this post with your network.
-
We're #hiring a new Hardware Engineering Manager in Mechelen, Flemish Region. Apply today or share this post with your network.
-
IDYLLA™ FIRST 💙 Guiding First-Line Therapy Decisions in NSCLC Download Idylla™ FIRST leaflet 👉🏻https://lnkd.in/eSEJpsAR #Biocartis #Idylla #IdyllaFirst #NSCLC #LungCancer #GeneFusion #NTRK #ALK #RET #ROS1 #EGFR
-
-
📣 Molecular biomarker results in only 3 hours! THINK IDYLLA™ But what does ‘molecular’ actually mean?... 🤔 💡 ‘Molecular diagnostics’ or ‘molecular pathology’ involves analyzing molecules (such as DNA, RNA and proteins) from a tissue or liquid sample for presence of biological markers that can pinpoint the potential (re-)emergence of a specific disease, such as cancer, and aid in planning and monitoring the patient’s treatment. 👉 Idylla™ makes molecular diagnostics convenient, fast and suitable for any lab: https://lnkd.in/gh9nKbMA #Biocartis #Idylla #MolecularDiagnostics #MolecularPathology